After investing in Keli Sensing, the Dianlian team has gained recognition and investment from three well-known angel investment institutions, Lihe Science and Technology Innovation, Sanze Venture Capital, and Changzhou Hermes, thanks to their strong professional technical capabilities and industry awareness.

Shenzhen Lihe Science and Technology Innovation Co., Ltd. is a high-tech enterprise and A-share listed state-owned enterprise controlled by Tsinghua University Research Institute in Shenzhen. It is an important member unit of Shenzhen Investment Control. With the mission of serving national innovation driven development, fulfilling the responsibility of Shenzhen's state-owned enterprise "dual zone" construction, adhering to high-level technological self-reliance and self-improvement, providing first-class scientific and technological innovation services, cultivating first-class scientific and technological enterprises, we have formed a distinctive "scientific and technological innovation service industry technology industry" business model, leveraging the advantages of deep integration of industry, academia, and research, committed to mass transformation of scientific and technological achievements, investment and incubation of hard technology enterprises, and focusing on new materials and new energy Cultivate high-quality projects in strategic emerging fields such as digital economy and future industries, and form the company's high-tech industry system. After years of development, Lihe Science and Technology Innovation has 38 innovation bases in the core areas with abundant scientific and technological innovation resources nationwide, and has jointly established 7 overseas innovation centers in North America and other places with the Research Institute of Tsinghua University in Shenzhen; We have incubated more than 3100 service enterprises, invested in nearly 500 high-tech enterprises, cultivated 30 listed companies, more than 160 "specialized, refined, special, and new" enterprises, more than 50 listed companies on the New Third Board, more than 300 national high-tech enterprises, and more than 200 technology achievement transformation projects.

Sanze Venture Capital was established in 2008 and is a member unit of the China Investment Association Entrepreneurship Investment Committee, the All China Federation of Industry and Commerce Medical and Pharmaceutical Industry Chamber of Commerce, and the Vice President unit of Guangdong Venture Capital Promotion Association and Hunan Equity Investment Association. The company focuses on investing in forward-looking industries such as healthcare, clean environment, and technological innovation, covering multiple stages of enterprise start-up, growth, and development. It has built a complete investment and operation management ecosystem and has been rated as the top 50 venture capital funds in China, the top 30 investment institutions in the field of big health in China, and the top 10 most influential private equity institutions in Hunan. Among the companies invested by Sanze Venture Capital, many have grown into the most influential in their respective fields, including Cambrian (688256), Lihe Technology (300800), Shandong Langjin (300594), Changsha Bank (601577), Keheng Shares (300340), Wanfu Biotechnology (300482), Kaiyuan Instruments (300338), Zhendong Pharmaceutical (300158), Xin Guodu (300130), Dana Biotechnology, Yingsheng Biotechnology, Hanhai New Enzyme, Nut Projection, etc. Sanze Venture Capital has always been committed to providing personalized investment and operation value-added services for investment enterprises, adhering to the concept of "Three Lives, All Things, and Together with Children", and wholeheartedly safeguarding the development of enterprises.